Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Integrated Freight and Logistics

Cryoport, Inc. provides cryogenic logistics solutions to the life sciences industry. The Company designs and manufactures temperature-sensitive and cryogenic packaging systems for the shipping of biological items. Cryoport also offers a proprietary logistics management platform that manages ordering, tracking, paperwork, customs documentation, and communications.
Website: cryoport.com


  • Bad financial results growth rate -11.4% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-19.5%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 2.3% (LTM)
  • Share price is 230.9% higher than minimum and 17.4% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (500.0x vs 30.0x)
  • For the last 3 months insiders sold company shares on $0.4 mln (-0.057% of cap.)

Key Financials (Download financials)

Ticker: CYRX
Share price, USD:  (+2.0%)15.55
year average price 11.69  


year start price 8.64 2025-09-13

min close price 8.33 2025-11-06

max close price 17.13 2026-08-21

current price 15.55 2026-09-12
Common stocks: 50 257 112

Dividend Yield:  0.0%
EV / Sales: 4.0x
Margin (EBITDA LTM / Revenue): -143.2%

Target EV / EBITDA (hist percentile): 30.0x
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 781
Net Debt ($m): -15
EV (Enterprise Value): 766
EBITDA LTM (млн $): -272
Price to Book: 1.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-12-02seekingalpha.com

Cryoport: Picks And Shovels For The Gene Therapy Boom

2025-11-04seekingalpha.com

Cryoport, Inc. (CYRX) Q3 2025 Earnings Call Transcript

2025-11-04zacks.com

CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates

2025-10-17zacks.com

CryoPort (CYRX) Moves 7.0% Higher: Will This Strength Last?

2025-08-05seekingalpha.com

Cryoport, Inc. (CYRX) Q2 2025 Earnings Call Transcript

2025-08-05zacks.com

CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates

2025-06-27zacks.com

CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know

2025-05-07seekingalpha.com

Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript

2025-03-31seekingalpha.com

Cryoport, Inc. (CYRX) Strategic Agreement and Transaction with DHL Group Call (Transcript)

2025-03-31prnewswire.com

DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-12 2024-11-07 2024-08-08 2024-05-08 2023-11-09 2023-08-09 2023-05-04 2022-11-04
acceptedDate 2025-11-06 14:33:28 2025-08-11 21:57:47 2025-03-07 17:02:31 2024-11-07 16:56:56 2024-08-08 14:55:32 2024-05-07 19:03:52 2024-03-13 17:26:29 2023-11-09 14:18:41 2023-08-09 16:47:13 2023-05-04 17:22:22 2023-02-28 17:08:32 2022-11-04 15:14:03 2022-02-28 17:24:45 2021-03-01 17:09:19
calendarYear 2025 2025 2023 2023 2023 2022 2022 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 44M 45M 233M 57M 58M 55M 237M 56M 57M 63M 223M 60M 223M 79M
costOfRevenue 23M 24M 134M 31M 37M 33M 133M 32M 32M 36M 126M 34M 126M 42M
grossProfit 21M 21M 99M 25M 21M 22M 104M 24M 25M 27M 97M 26M 97M 36M
grossProfitRatio 0.482 0.47 0.448 0.363 0.399 0.432 0.434 0.431 0.437
researchAndDevelopmentExpenses 5M 4M 18M 4M 5M 5M 16M 5M 4M 4M 17M 4M 17M 9M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 27M 27M 147M 38M 31M 38M 120M 36M 39M 33M 98M 30M 98M 57M
otherExpenses 0 0 50M 0 -1M 1M 0 -3M -704 000 4M 0 0 0 0
operatingExpenses 31M 31M 214M 42M 36M 43M 136M 41M 43M 37M 114M 34M 114M 66M
costAndExpenses 54M 55M 348M 73M 73M 76M 269M 73M 75M 73M 240M 68M 240M 109M
interestIncome 3M 0 0 0 0 0 0 3M 3M 0 0 0 0 0
interestExpense 526 000 618 000 6M 889 000 1M 1M 6M 1M 1M 2M 5M 2M 5M 3M
depreciationAndAmortization 6M 7M 27M 8M 8M 7M 23M -3M 7M 4M 20M 7M 20M 10M
ebitda 410 000 -4M -66M 10M -69M -12M -6M -20M -12M -6M -249M -349 000 -249M -20M
ebitdaratio 0.009 -0.084 0.18 -0.128 -0.228 -0.356 -0.216 -0.096 -0.006
operatingIncome -10M -10M -115M -16M -15M -21M -32M -17M -18M -10M -18M -8M -18M -30M
operatingIncomeRatio -0.225 -0.212 -0.29 -0.259 -0.39 -0.301 -0.321 -0.16 -0.129
totalOtherIncomeExpensesNet 3M -2M 16M 18M 2M 4M -3M 5M 2M 5M -256M 3M -256M -3M
incomeBeforeTax -7M -12M -99M 1M -78M -19M -35M -13M -18M -5M -274M -5M -274M -33M
incomeBeforeTaxRatio -0.148 -0.258 0.026 -1.347 -0.342 -0.228 -0.311 -0.081 -0.087
incomeTaxExpense 165 000 274 000 239 000 649 000 383 000 215 000 2M 471 000 635 000 492 000 2M 57 000 2M -45 000
netIncome -7M 105M -100M 805 000 -78M -19M -37M -13M -18M -6M -276M -5M -276M -33M
netIncomeRatio -0.157 2.314 0.014 -1.354 -0.346 -0.236 -0.322 -0.089 -0.088
eps -0.18 2.05 -2.21 -0.024 -1.58 -0.39 -0.93 -0.27 -0.38 -0.12 -6.18 -0.11 -6.18 -1.94
epsdiluted -0.18 2.05 -0.024 -1.58 -0.39 -0.27 -0.38 -0.12 -0.11
weightedAverageShsOut 50M 50M 49M 49M 49M 49M 49M 49M 49M 48M 46M 49M 46M 39M
weightedAverageShsOutDil 50M 50M 49M 49M 49M 49M 49M 49M 49M 48M 46M 49M 46M 39M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-07 2024-03-13 2023-02-28 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -6M -6M -5M -5M -3M
ebit -94M -29M -269M -269M -30M
nonOperatingIncomeExcludingInterest -21M -3M 251M 251M 168 000
netIncomeFromContinuingOperations -100M -37M -276M -276M -33M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 42M
bottomLineNetIncome -108M -45M -284M -284M -75M
epsDiluted -2.21 -0.93 -6.18 -6.18 -1.94

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-12 2024-11-07 2024-08-08 2024-05-08 2023-11-09 2023-08-09 2023-05-04 2022-11-04
acceptedDate 2025-11-06 14:33:28 2025-08-11 21:57:47 2025-03-07 17:02:31 2024-11-07 16:56:56 2024-08-08 14:55:32 2024-05-07 19:03:52 2024-03-13 17:26:29 2023-11-09 14:18:41 2023-08-09 16:47:13 2023-05-04 17:22:22 2023-02-28 17:08:32 2022-11-04 15:14:03 2022-02-28 17:24:45 2021-03-01 17:09:19
calendarYear 2025 2025 2023 2023 2023 2022 2022 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 256M 36M 45M 45M 46M 50M 46M 59M 67M 39M 37M 31M 139M 37M
shortTermInvestments 166M 208M 216M 228M 381M 399M 410M 406M 437M 484M 487M 499M 490M 56M
cashAndShortTermInvestments 421M 244M 262M 273M 427M 449M 457M 466M 505M 523M 523M 530M 629M 93M
netReceivables 33M 28M 46M 43M 40M 41M 42M 43M 43M 46M 44M 44M 39M 31M
inventory 23M 23M 22M 24M 24M 25M 26M 29M 29M 26M 28M 25M 17M 11M
otherCurrentAssets 12M 116M 12M 11M 11M 11M 10M 12M 9M 10M 9M 11M 0 0
totalCurrentAssets 489M 411M 342M 350M 502M 526M 535M 549M 585M 605M 604M 609M 694M 147M
propertyPlantEquipmentNet 120M 120M 136M 118M 116M 117M 118M 107M 99M 102M 90M 83M 70M 44M
goodwill 19M 21M 52M 54M 52M 108M 108M 149M 149M 152M 151M 147M 147M 145M
intangibleAssets 144M 145M 170M 176M 178M 190M 194M 193M 195M 188M 191M 192M 201M 214M
goodwillAndIntangibleAssets 162M 166M 222M 230M 231M 298M 303M 342M 344M 340M 342M 340M 348M 359M
longTermInvestments 0 0 0 0 0 -758 001 0 0 0 0 0 0 0 0
taxAssets 267 000 614 000 868 000 2M 2M 758 000 656 000 863 000 934 000 937 000 947 000 2M 419 000 0
otherNonCurrentAssets 2M 2M 3M 1M 2M 2M 2M 2M 1M 1M 1M 926 000 950 000 2M
totalNonCurrentAssets 284M 289M 362M 351M 350M 417M 423M 452M 445M 443M 435M 425M 419M 405M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 774M 700M 703M 702M 852M 943M 958M 1 001M 1 031M 1 048M 1 039M 1 034M 1 113M 552M
accountPayables 15M 13M 26M 0 25M 27M 26M 28M 26M 26M 27M 0 29M 25M
shortTermDebt 9M 18M 14M 6M 20M 6M 149 000 5M 4M 4M 60 000 4M 0 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 2M 2M 1M 1M 1M 2M 1M 2M 927 000 1M 439 000 549 000 547 000 445 000
otherCurrentLiabilities 5M 40M 4M 54M 14M 14M 4M 10M 9M 10M 3M 36M 2M 1M
totalCurrentLiabilities 31M 74M 65M 61M 60M 49M 46M 45M 40M 42M 41M 41M 43M 35M
longTermDebt 226M 224M 185M 227M 385M 409M 380M 409M 436M 436M 407M 430M 405M 116M
deferredRevenueNonCurrent 0 0 0 0 28M 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 664 000 878 000 3M 4M 3M 2M 3M 5M 5M 5M 5M 3M 4M 6M
otherNonCurrentLiabilities 3M 2M 4M 0 5M 10M 10M 5M 5M 5M 5M 433M 1M 176 000
totalNonCurrentLiabilities 230M 227M 237M 230M 392M 422M 423M 418M 446M 446M 442M 437M 428M 135M
otherLiabilities 0 0 0 -9M 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 45M 43M 51M 0 33M 34M 36M 35M 33M 32M 29M 26M 22M 15M
totalLiabilities 261M 301M 302M 283M 452M 471M 469M 463M 486M 488M 483M 478M 471M 170M
preferredStock 38M 36M 34M 32M 30M 28M 26M 24M 22M 20M 18M 16M 10M 3M
commonStock 50 000 50 000 50 000 49 000 49 000 49 000 49 000 49 000 49 000 48 000 48 000 49 000 50 000 40 000
retainedEarnings -668M -769M -757M -738M -739M -661M -642M -580M -567M -548M -543M -504M -468M -192M
accumulatedOtherComprehensiveIncomeLoss -5M -16M -21M -16M -29M -30M -26M -34M -34M -30M -35M -43M -1M 5M
othertotalStockholdersEquity 1 151M 1 147M 1 141M 1 138M 1 135M 1 127M 1 123M 1 118M 1 086M
totalStockholdersEquity 515M 399M 402M 419M 400M 472M 489M 538M 544M 561M 556M 556M 642M 383M
totalEquity 515M 399M 402M 419M 400M 472M 489M 538M 544M 561M 556M 556M 642M 383M
totalLiabilitiesAndStockholdersEquity 774M 700M 702M 852M 943M 1 001M 1 031M 1 048M 1 034M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 774M 700M 703M 702M 852M 943M 958M 1 001M 1 031M 1 048M 1 039M 1 034M 1 113M 552M
totalInvestments 166M 208M 216M 228M 381M 399M 410M 406M 437M 484M 487M 499M 490M 56M
totalDebt 231M 243M 251M 233M 405M 415M 416M 414M 441M 440M 436M 434M 427M 131M
netDebt -25M 207M 205M 189M 358M 365M 370M 354M 374M 401M 399M 403M 288M 94M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-07 2024-03-13 2023-02-28 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 46M 42M 44M 39M 31M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 9M 12M
totalPayables 26M 26M 27M 29M 25M
otherPayables 0 0 0 0 0
accruedExpenses 13M 9M 6M 8M 6M
capitalLeaseObligationsCurrent 6M 6M 4M 4M 2M
capitalLeaseObligationsNonCurrent 45M 30M 25M 18M 12M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 146M 1 131M 1 115M 1 100M 566M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-12 2024-11-07 2024-08-08 2024-05-08 2023-11-09 2023-08-09 2023-05-04 2022-11-04 2022-08-04
acceptedDate 2025-11-06 14:33:28 2025-08-11 21:57:47 2025-03-07 17:02:31 2024-11-07 16:56:56 2024-08-08 14:55:32 2024-05-07 19:03:52 2024-03-13 17:26:29 2023-11-09 14:18:41 2023-08-09 16:47:13 2023-05-04 17:22:22 2023-02-28 17:08:32 2022-11-04 15:14:03 2022-08-04 17:04:07 2022-02-28 17:24:45 2021-03-01 17:09:19
calendarYear 2025 2025 2023 2023 2023 2022 2022 2022 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome -7M -12M -115M 805 000 -78M -19M -100M -13M -18M -6M -37M -5M -9M -276M -33M
depreciationAndAmortization 6M 7M 31M 8M 8M 7M 27M 7M 7M 6M 23M 6M 5M 20M 10M
deferredIncomeTax -299 000 1M 0 639 000 -471 000 -551 000 -2M -3M 2M 246 000 0 0 0 254M 858 000
stockBasedCompensation 0 0 20M 5M 5M 5M 23M 6M 6M 5M 20M 5M 5M 15M 9M
changeInWorkingCapital -1M -10M -9M 4M -6M 2M 780 000 34 000 -1M -2M -32M -5M -17M -7M -2M
accountsReceivables -2M -7M -4M -3M 1M 437 000 4M -16 000 3M -1M -4M -4M -8M -7M -3M
inventory -421 000 638 000 3M 284 000 1M 1M 2M -325 000 -2M 1M -14M -2M -2M -6M 1M
accountsPayables -129 000 -2M -76 000 -728 000 -3M 264 000 -3M -60 000 -1M -3M -6M 0 0 3M 4M
otherWorkingCapital 1M -2M -8M 7M -5M -89 000 -2M 435 000 -300 000 1M -7M 612 000 -4M 3M -5M
otherNonCashItems 4M 6M 57M -17M 84M 2M 50M 2M 2M -1M 25M 253 000 0 1M 437 000
netCashProvidedByOperatingActivities 2M -7M -16M 447 000 -8M -3M -757 000 -2M -4M 3M -2M 982 000 -7M 8M -15M
investmentsInPropertyPlantAndEquipment -4M -6M -17M -1M -6M -5M -39M -11M -11M -10M -22M -6M -5M -24M -9M
acquisitionsNet 0 210M 0 0 0 0 -7M 0 0 0 -7M -4M 0 -6M -363M
purchasesOfInvestments 0 0 -51M -2M -36M -14M -43M 0 0 -2M -164M -19M -106M -483M -159M
salesMaturitiesOfInvestments 19M 26M 249M 164M 55M 25M 130M 30M 45M 8M 132M 23M 49M 44M 149M
otherInvestingActivites 0 0 -6M 17M 977 000 27M 0 2M 0 -2M
netCashUsedForInvestingActivites 14M 230M 154M 13M 6M 19M 34M -1M -6M -64M
debtRepayment -146 000 -15M -155M -9M -106 000 -25M -50 000 -31 000 -1M -644 000
commonStockIssued 1M 3M -627 000 9000 618 000 180 000 1M 92 000 0 0
commonStockRepurchased -4M -4M 0 0 0 0 0 0 0 0 -38M 0 -25M 0 0
dividendsPaid -6M 0 0 0 -2M 0 0 -2M 0 0
otherFinancingActivites 6M 0 21 000 9000 3M 180 000 -10000 2M 999 000 284 000
netCashUsedProvidedByFinancingActivities -3M -16M -155M -9M 512 000 -25M 1M 71 000 -459 000 -25M
effectOfForexChangesOnCash -1M 484 000 -18 000 -519 000 263 000 -375 000 -2M 499 000 -2M 481 000 -2M -968 000 -1M -985 999 1M
netChangeInCash 12M 207M -1M -2M -3M 3M 10M -8M 29M 2M -103M -6M -97M 102M -10M
cashAtEndOfPeriod 256M 243M 45M 45M 46M 50M 46M 59M 67M 39M 37M 31M 37M 139M 37M
cashAtBeginningOfPeriod 243M 36M 46M 46M 50M 46M 37M 67M 39M 37M 139M 37M 134M 37M 47M
operatingCashFlow 2M -7M -16M 447 000 -8M -3M -757 000 -2M -4M 3M -2M 982 000 -7M 8M -15M
capitalExpenditure -3M -4M -17M -1M -6M -5M -45M -11M -11M -10M -24M -6M -5M -25M -10M
freeCashFlow -1M -12M -34M -1M -14M -8M -46M -13M -15M -7M -26M -5M -12M -17M -25M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-03-07 2024-03-13 2023-02-28 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -4M -5M 910 000 -1M -751 000
netCashProvidedByInvestingActivities 177M 36M -60M -469M -382M
netDebtIssuance -164M -25M -3M 37M 115M
longTermNetDebtIssuance -164M -25M -3M 37M 115M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 3M 1M -36M 528M 275M
netCommonStockIssuance 3M 1M -36M 528M 275M
commonStockIssuance 3M 1M 2M 528M 275M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 0 0 0 0 0
netCashProvidedByFinancingActivities -162M -24M -39M 564M 386M
incomeTaxesPaid 1M 1M 2M 1M 60 000
interestPaid 3M 3M 4M 3M 2M

Earning call transcript

2025 q3
2025-11-04 ET (fiscal 2025 q3)
2025 q2
2025-08-05 ET (fiscal 2025 q2)
2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-03-04 ET (fiscal 2024 q4)
2024 q3
2024-11-09 ET (fiscal 2024 q3)
2024 q2
2024-08-06 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-03-12 ET (fiscal 2023 q4)
2023 q3
2023-11-09 ET (fiscal 2023 q3)
2023 q2
2023-08-09 ET (fiscal 2023 q2)
2023 q1
2023-05-05 ET (fiscal 2023 q1)
2022 q4
2023-02-23 ET (fiscal 2022 q4)
2022 q3
2022-11-05 ET (fiscal 2022 q3)
2022 q2
2022-08-06 ET (fiscal 2022 q2)
2022 q1
2022-05-07 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-08-06 ET
Cryoport Reports Second Quarter 2026 Financial Results
2026-07-23 ET
Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-06-25 ET
Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs
2026-05-04 ET
Cryoport Reports First Quarter 2026 Financial Results
2026-04-20 ET
Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026
2026-03-03 ET
Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results
2026-02-17 13:00 ET
Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
2026-02-11 13:30 ET
Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series
2025-11-04 ET
Cryoport Reports Third Quarter 2025 Financial Results
2025-10-30 ET
Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain
2025-10-21 ET
Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025
2025-10-07 ET
MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars
2025-10-01 ET
Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France
2025-08-05 ET
Cryoport Reports Second Quarter 2025 Financial Results
2025-07-22 ET
Cryoport to Report Second Quarter 2025 Financial Results on August 5, 2025
2025-07-08 ET
Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers
2025-06-12 ET
Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group
2025-05-07 ET
Cryoport Reports First Quarter 2025 Financial Results
2025-04-24 ET
Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025
2025-03-31 ET
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
2025-03-31 ET
Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET
2025-03-12 ET
Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories
2025-03-04 ET
Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results
2025-02-18 ET
Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
2025-01-21 ET
Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies
2025-01-14 ET
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
2025-01-06 ET
Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")
2024-11-12 ET
Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe
2024-11-07 ET
Cryoport Reports Third Quarter 2024 Financial Results
2024-10-29 12:30 ET
Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024
2024-10-22 12:30 ET
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
2024-10-21 12:30 ET
TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics
2024-10-15 12:30 ET
VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies
2024-10-07 12:30 ET
Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus
2024-09-25 12:30 ET
SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
2024-08-06 20:15 ET
Cryoport Reports Second Quarter 2024 Financial Results
2024-08-06 20:05 ET
Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes
2024-07-23 12:30 ET
Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024
2024-06-20 12:30 ET
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
2024-05-07 20:08 ET
Cryoport Reports First Quarter 2024 Financial Results
2024-04-30 12:30 ET
Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024
2024-03-12 20:05 ET
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-27 13:30 ET
Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
2023-11-27 13:30 ET
Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services
2023-11-16 13:30 ET
Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express
2023-11-08 21:05 ET
Cryoport Reports Third Quarter 2023 Financial Results
2023-11-02 12:30 ET
Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition
2023-10-25 12:30 ET
Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023
2023-10-12 12:30 ET
Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF
2023-10-10 12:30 ET
Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies
2023-10-09 20:05 ET
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
2023-09-14 12:30 ET
Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award
2023-08-09 20:05 ET
Cryoport Reports Second Quarter 2023 Financial Results
2023-08-02 12:30 ET
Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023
2023-07-12 20:05 ET
Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations
2023-06-29 12:39 ET
IVFAustralia Selects Cryoport as Exclusive Supply Chain Solutions Provider
2023-05-04 20:05 ET
Cryoport Reports First Quarter 2023 Results
2023-04-27 12:30 ET
Cryoport to Report First Quarter 2023 Financial Results on May 4, 2023
2023-04-25 12:30 ET
Cryoport Signs New Supply Chain Solutions Agreement with Boston IVF to Support Reproductive Material Shipments Across the U.S.
2023-03-28 12:30 ET
Cryoport Announces Multi-Year Agreement with Inception Fertility
2023-03-13 10:00 ET
Cryoport Confirms No Financial Exposure to Silicon Valley Bank
2023-03-08 18:15 ET
Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?
2023-02-23 21:05 ET
Cryoport Reports Fourth Quarter and Full Year 2022 Results
2023-02-15 13:30 ET
Cryoport to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
2023-01-18 13:30 ET
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
2022-12-20 13:30 ET
Cryoport to Present at the J.P. Morgan 41st Annual Healthcare Conference
2022-11-03 20:05 ET
Cryoport Reports Results for the Third Quarter 2022
2022-10-27 12:30 ET
Cryoport to Report Third Quarter 2022 Financial Results on November 3, 2022
2022-09-08 12:30 ET
Cryoport Enters into Strategic Relationship with Takeda's BioLife Plasma Services
2022-08-04 20:05 ET
Cryoport Reports Results for the Second Quarter 2022
2022-07-28 12:30 ET
Cryoport to Report Second Quarter 2022 Financial Results on August 4, 2022
2022-05-05 20:05 ET
Cryoport Reports First Quarter 2022 Results
2022-04-28 12:30 ET
Cryoport to Report First Quarter 2022 Financial Results on May 5, 2022
2022-04-18 12:30 ET
Cryoport Acquires Cell&Co BioServices
2022-03-30 21:00 ET
Cryoport's MVE Biological Solutions' New Prague Manufacturing Plant Returns to Full Production
2022-03-11 20:40 ET
Cryoport Authorizes $100 Million Repurchase Program
2022-03-11 ET
Cryoport Authorizes $100 Million Repurchase Program
2022-02-24 21:05 ET
Cryoport Reports Fourth Quarter and Full Year 2021 Results
2022-02-15 13:30 ET
Cryoport Report's Fourth Quarter and 2021 Financial Results on February 24, 2022
2022-02-09 14:29 ET
Cryoport Provides Positive Update on MVE Biological Solution's New Prague Facility
2022-01-31 22:35 ET
Cryoport Reports Fire Damage at MVE's New Prague Facility
2022-01-27 13:30 ET
Cryoport and Cell Matters Enter into Strategic Partnership
2022-01-05 13:30 ET
Cryoport to Present at the J.P. Morgan 40th Annual Healthcare Conference
2021-11-10 05:20 ET
Cryoport, Inc. Prices Upsized $350.0 Million Convertible Senior Notes Offering
2021-11-10 05:20 ET
Cryoport, Inc. Prices Registered Direct Placement of Common Stock
2021-11-10 ET
Cryoport, Inc. Prices Upsized $350.0 Million Convertible Senior Notes Offering
2021-11-08 21:33 ET
Cryoport, Inc. Announces Proposed Convertible Senior Notes Offering
2021-11-08 21:29 ET
Cryoport, Inc. Announces Proposed Registered Direct Placement of Common Stock
2021-11-04 20:05 ET
Cryoport Reports Record Third Quarter and Nine Months Revenue for 2021
2021-10-29 14:30 ET
CRYOPDP, a Cryoport Company, Receives 2021 Europe Bioprocessing Excellence Award from IMAPAC
2021-10-28 20:15 ET
Cryoport to Report Third Quarter 2021 Financial Results on November 4, 2021
2021-08-25 12:15 ET
Cryoport and Mitsubishi Logistics Corporation Partner to Bring Temperature-Controlled Supply Chain Solutions to Asia-Pacific
2021-08-05 20:05 ET
Cryoport Reports Record Second Quarter 2021 Revenue
2021-07-29 12:30 ET
Cryoport to Report Second Quarter 2021 Financial Results on August 5, 2021
2021-06-22 12:30 ET
Cellenkos® Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need
2021-05-19 11:30 ET
Cryoport Further Expands its Asia Pacific Operations with New Global Logistics Center in Singapore
2021-05-18 11:30 ET
Cryoport Expands Global Supply Chain Network with Belgium Acquisition
2021-05-06 12:30 ET
LabConnect and Cryoport Partner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical Trial
2021-05-04 20:05 ET
Cryoport Revenue Climbs to $53.3 Million for First Quarter 2021
2021-05-04 ET
Cryoport Revenue Climbs to $53.3 Million for First Quarter 2021
2021-04-27 12:30 ET
Cryoport to Report First Quarter 2021 Financial Results on May 4, 2021
2021-04-06 12:30 ET
Cryoport Acquires Temperature-Controlled Logistics Provider in Australia
2021-03-03 21:08 ET
Cryoport Announces Appointment of Linda Baddour to its Board of Directors
2021-03-01 21:13 ET
Cryoport Reports Record Results for Full Year 2020
2021-02-25 13:45 ET
Cryoport to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 1, 2021
2021-02-25 13:15 ET
Cryoport Launches Environmental, Social, and Governance (ESG) Program
2021-02-08 13:00 ET
Blackstone Converts $51 million of Cryoport Series C Preferred Stock Into Common Stock
2021-02-08 ET
Blackstone Converts $51 million of Cryoport Series C Preferred Stock Into Common Stock
2021-01-25 17:22 ET
Cryoport Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters to Purchase Additional Shares
2021-01-21 03:30 ET
Cryoport Announces Pricing of Public Offering of Common Stock
2021-01-19 22:02 ET
Cryoport Announces Proposed Public Offering of Common Stock
2020-12-08 13:30 ET
Cryoport and CCRM Fertility Enter Into Agreement
2020-11-05 21:05 ET
Cryoport Reports 2020 Third-Quarter Results
2020-10-29 18:15 ET
Cryoport to Report Third Quarter 2020 Financial Results on November 5, 2020
2020-10-01 16:49 ET
Cryoport Completes Acquisitions of MVE Biological Solutions and CRYOPDP
2020-08-25 11:00 ET
Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries
2020-08-21 11:30 ET
Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP
2020-08-06 20:05 ET
Cryoport Reports 2020 Second-Quarter Results
2020-08-04 12:30 ET
MEDIPAL HOLDINGS Partners with CRYOPORT to Bring Temperature-Controlled Supply Chain Solutions to the Japanese Market
2020-08-03 20:10 ET
Cryoport to Report Second Quarter 2020 Financial Results on August 6, 2020
2020-05-21 11:00 ET
Cryoport, Inc. Prices $100.0 Million Convertible Senior Notes Offering
2020-05-19 22:54 ET
Cryoport, Inc. Announces Proposed Convertible Senior Notes Offering
2020-05-07 20:05 ET
/C O R R E C T I O N -- Cryoport, Inc./
2020-04-30 12:30 ET
Cryoport to Report First Quarter 2020 Financial Results on May 7, 2020
2020-03-05 21:05 ET
Cryoport Reports Record Revenue for Fiscal Year 2019
2020-02-27 13:30 ET
Cryoport to Report Fourth Quarter and Fiscal Year 2019 Financial Results on March 5, 2020
2020-02-26 13:30 ET
Cryoport and Inception Fertility Enter Into Agreement
2019-11-05 14:00 ET
Lonza Partners with Cryoport and Strengthens its 'Vein-to-vein' Delivery Network in Cell & Gene Therapy
2019-10-31 12:30 ET
Cryoport to Report Third Quarter 2019 Financial Results on November 7, 2019
2019-10-09 13:00 ET
Cryoport Authorizes Share Repurchase Program and Presenting at Upcoming Investor Conferences
2019-09-18 12:30 ET
Cryoport Introduces Cell & Gene Industry's First Dedicated Shipper for Advanced Therapies
2019-08-08 20:05 ET
Cryoport Revenue Grows 83% for Second Quarter 2019
2019-07-25 12:30 ET
Cryoport to Report Second Quarter 2019 Financial Results on August 8th, 2019
2019-07-11 12:30 ET
Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain
2019-06-20 01:02 ET
Cryoport Announces Pricing of Public Offering of Common Stock
2019-06-19 20:03 ET
Cryoport Announces Proposed Public Offering of Common Stock
2019-06-05 12:30 ET
Cryoport to Ring the Nasdaq Closing Bell on Monday, June 10 and Attend Jefferies 2019 Healthcare Conference June 4  -7  , 2019
2019-05-14 21:22 ET
Cryoport Expands into Biostorage through the Acquisition of Cryogene
2019-05-02 20:05 ET
Cryoport Revenue Grows 65% for First Quarter 2019
2019-04-25 12:30 ET
Cryoport to Report First Quarter 2019 Financial Results on May 2nd, 2019
2019-04-11 12:30 ET
Celularity Selects Cryoport's Temperature Controlled Logistics Solutions

SEC forms

Show financial reports only

SEC form 10
2026-08-06 21:03 ET
CryoPort published news for 2026 q2
SEC form 8
2026-08-06 20:30 ET
CryoPort published news for 2026 q2
SEC form 8
2026-08-06 20:30 ET
CryoPort published news for 2026 q2
SEC form 8
2026-06-09 21:00 ET
CryoPort published news for 2026 q1
SEC form 8
2026-06-09 21:00 ET
CryoPort published news for 2026 q1
SEC form 10
2026-05-05 18:36 ET
CryoPort published news for 2026 q1
SEC form 8
2026-05-04 20:30 ET
CryoPort published news for 2026 q1
SEC form 8
2026-05-04 20:30 ET
CryoPort published news for 2026 q1
SEC form 10
2026-03-05 21:53 ET
CryoPort published news for 2025 q4
SEC form 8
2026-03-03 17:10 ET
CryoPort published news for 2025 q4
SEC form 8
2026-03-03 17:10 ET
CryoPort published news for 2025 q4
SEC form 10
2025-11-06 14:33 ET
CryoPort reported for 2025 q3
SEC form 8
2025-11-04 17:18 ET
CryoPort published news for 2025 q3
SEC form 8
2025-11-04 17:18 ET
CryoPort reported for 2025 q3
SEC form 10
2025-08-12 01:57 ET
CryoPort published news for 2025 q2
SEC form 8
2025-08-05 21:39 ET
CryoPort published news for 2025 q2
SEC form 8
2025-08-05 21:39 ET
CryoPort reported for 2025 q2
SEC form 8
2025-06-13 19:55 ET
CryoPort published news for 2025 q1
SEC form 8
2025-06-13 19:55 ET
CryoPort published news for 2025 q1
SEC form 8
2025-06-13 19:55 ET
CryoPort published news for 2025 q1
SEC form 10
2025-05-08 21:18 ET
CryoPort published news for 2025 q1
SEC form 10
2025-05-08 00:00 ET
CryoPort published news for 2025 q1
SEC form 8
2025-05-07 20:16 ET
CryoPort published news for 2025 q1
SEC form 8
2025-05-07 20:16 ET
CryoPort reported for 2025 q1
SEC form 8
2025-03-31 12:17 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-31 12:17 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-31 12:17 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-31 12:17 ET
CryoPort published news for 2024 q4
SEC form 10
2025-03-07 22:02 ET
CryoPort published news for 2024 q4
SEC form 10
2025-03-07 00:00 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-04 17:07 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-04 17:07 ET
CryoPort reported for 2024 q4
SEC form 10
2024-11-07 16:56 ET
CryoPort reported for 2024 q3
SEC form 8
2024-11-07 16:31 ET
CryoPort published news for 2024 q3
SEC form 8
2024-11-07 16:31 ET
CryoPort published news for 2024 q3
SEC form 10
2024-08-08 00:00 ET
CryoPort published news for 2024 q2
SEC form 8
2024-08-06 17:17 ET
CryoPort published news for 2024 q2
SEC form 8
2024-08-06 17:17 ET
CryoPort reported for 2024 q2
SEC form 10
2024-05-08 00:00 ET
CryoPort published news for 2024 q1
SEC form 10
2024-05-07 19:03 ET
CryoPort published news for 2024 q1
SEC form 8
2024-05-07 16:53 ET
CryoPort published news for 2024 q1
SEC form 8
2024-05-07 16:53 ET
CryoPort reported for 2024 q1
SEC form 10
2024-03-13 17:26 ET
CryoPort published news for 2023 q4
SEC form 10
2024-03-13 00:00 ET
CryoPort published news for 2023 q4
SEC form 8
2024-03-12 16:30 ET
CryoPort published news for 2023 q4
SEC form 8
2024-03-12 16:30 ET
CryoPort reported for 2023 q4
SEC form 10
2023-11-09 00:00 ET
CryoPort published news for 2023 q3
SEC form 8
2023-11-08 16:31 ET
CryoPort reported for 2023 q3
SEC form 6
2023-08-09 17:28 ET
CryoPort published news for 2023 q2
SEC form 10
2023-08-09 16:47 ET
CryoPort reported for 2023 q2
SEC form 10
2023-08-09 00:00 ET
CryoPort published news for 2023 q2
SEC form 8
2023-08-09 00:00 ET
CryoPort published news for 2023 q2
SEC form 6
2023-07-12 16:31 ET
CryoPort published news for 2023 q2
SEC form 8
2023-07-12 00:00 ET
CryoPort published news for 2023 q2
SEC form 10
2023-05-04 00:00 ET
CryoPort published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
CryoPort published news for 2023 q1
SEC form 6
2023-03-28 17:15 ET
CryoPort published news for 2022 q4
SEC form 6
2023-03-15 16:31 ET
CryoPort published news for 2022 q4
SEC form 10
2023-02-28 17:08 ET
CryoPort published news for 2022 q4
SEC form 10
2023-02-28 00:00 ET
CryoPort reported for 2022 q4
SEC form 6
2023-02-23 16:47 ET
CryoPort published news for 2022 q4
SEC form 8
2023-02-23 00:00 ET
CryoPort reported for 2022 q4
SEC form 10
2022-11-04 15:14 ET
CryoPort published news for 2022 q3
SEC form 10
2022-11-04 00:00 ET
CryoPort reported for 2022 q3
SEC form 6
2022-11-03 16:30 ET
CryoPort published news for 2022 q3
SEC form 8
2022-11-03 00:00 ET
CryoPort reported for 2022 q3
SEC form 10
2022-08-04 17:04 ET
CryoPort published news for 2022 q2
SEC form 6
2022-08-04 16:31 ET
CryoPort published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
CryoPort reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
CryoPort reported for 2022 q2
SEC form 10
2022-05-05 17:02 ET
CryoPort published news for 2022 q1
SEC form 6
2022-05-05 16:26 ET
CryoPort published news for 2022 q1
SEC form 6
2022-05-05 11:49 ET
CryoPort published news for 2022 q1
SEC form 10
2022-05-05 00:00 ET
CryoPort reported for 2022 q1
SEC form 8
2022-05-05 00:00 ET
CryoPort reported for 2022 q1
SEC form 6
2022-03-21 16:30 ET
CryoPort published news for 2021 q4
SEC form 6
2022-03-18 16:59 ET
CryoPort published news for 2021 q4
SEC form 6
2022-03-11 17:28 ET
CryoPort published news for 2021 q4
SEC form 10
2022-02-28 17:24 ET
CryoPort published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
CryoPort published news for 2021 q4
SEC form 6
2022-02-24 17:31 ET
CryoPort published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
CryoPort published news for 2021 q4
SEC form 6
2022-02-09 16:32 ET
CryoPort published news for 2021 q4
SEC form 6
2022-01-31 17:44 ET
CryoPort published news for 2021 q4
SEC form 6
2021-11-12 17:10 ET
CryoPort published news for 2021 q3
SEC form 6
2021-11-10 06:06 ET
CryoPort published news for 2021 q3
SEC form 6
2021-11-08 16:44 ET
CryoPort published news for 2021 q3
SEC form 10
2021-11-04 17:12 ET
CryoPort published news for 2021 q3
SEC form 6
2021-11-04 16:53 ET
CryoPort published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
CryoPort published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
CryoPort published news for 2021 q3
SEC form 10
2021-08-06 00:00 ET
CryoPort published news for 2021 q2
SEC form 10
2021-08-05 18:42 ET
CryoPort published news for 2021 q2
SEC form 6
2021-08-05 17:07 ET
CryoPort published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
CryoPort published news for 2021 q2
SEC form 10
2021-05-06 17:11 ET
CryoPort published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
CryoPort published news for 2021 q1
SEC form 6
2021-05-05 17:23 ET
CryoPort published news for 2021 q1
SEC form 6
2021-05-04 16:43 ET
CryoPort published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
CryoPort published news for 2021 q1
SEC form 6
2021-03-16 16:45 ET
CryoPort published news for 2020 q4
SEC form 6
2021-03-03 17:08 ET
CryoPort published news for 2020 q4
SEC form 6
2021-03-01 17:21 ET
CryoPort published news for 2020 q4
SEC form 10
2021-03-01 17:09 ET
CryoPort published news for 2020 q4
SEC form 6
2021-02-08 16:26 ET
CryoPort published news for 2020 q4
SEC form 6
2021-01-25 16:51 ET
CryoPort published news for 2020 q4
SEC form 6
2021-01-20 16:44 ET
CryoPort published news for 2020 q4
SEC form 6
2021-01-19 17:09 ET
CryoPort published news for 2020 q4
SEC form 6
2021-01-19 06:09 ET
CryoPort published news for 2020 q4
SEC form 6
2020-12-14 16:01 ET
CryoPort published news for 2020 q3
SEC form 10
2020-11-06 17:19 ET
CryoPort published news for 2020 q3
SEC form 6
2020-11-05 16:31 ET
CryoPort published news for 2020 q3
SEC form 6
2020-10-01 16:15 ET
CryoPort published news for 2020 q3